Antibacterial treatment strategies in hospitalized patients: What role for pharmacoeconomics?

Morton P. Goldman, PharmD, BCPS
Director, Pharmacotherapy Services, Department of Pharmacy, Cleveland Clinic, Cleveland, OH

Radhika Nair, PhD
Health Sciences Researcher, Abbott Laboratories, Austin, TX*

Correspondence: Morton P. Goldman, PharmD, BCPS, Department of Pharmacy, QQb5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

*At the time this article was written, Dr. Nair was Outcomes Research Specialist, Department of Pharmacy, Cleveland Clinic, Cleveland, OH.

Dr. Goldman reported that he has received fees for serving on speakers’ bureaus for Enzon Pharmaceuticals, Wyeth Pharmaceuticals, Abbott Laboratories, Schering-Plough Corp., Forest Laboratories, and Pfizer Inc., and that he has received honoraria for writing from Wyeth.

Dr. Nair reported that she receives a salary from Abbott Laboratories (her current employer) and that she has received honoraria for writing from Wyeth.

The authors reported that they prepared this article without assistance from any medical education company.

Morton P. Goldman, PharmD, BCPS
Director, Pharmacotherapy Services, Department of Pharmacy, Cleveland Clinic, Cleveland, OH

Radhika Nair, PhD
Health Sciences Researcher, Abbott Laboratories, Austin, TX*

Correspondence: Morton P. Goldman, PharmD, BCPS, Department of Pharmacy, QQb5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

*At the time this article was written, Dr. Nair was Outcomes Research Specialist, Department of Pharmacy, Cleveland Clinic, Cleveland, OH.

Dr. Goldman reported that he has received fees for serving on speakers’ bureaus for Enzon Pharmaceuticals, Wyeth Pharmaceuticals, Abbott Laboratories, Schering-Plough Corp., Forest Laboratories, and Pfizer Inc., and that he has received honoraria for writing from Wyeth.

Dr. Nair reported that she receives a salary from Abbott Laboratories (her current employer) and that she has received honoraria for writing from Wyeth.

The authors reported that they prepared this article without assistance from any medical education company.

Morton P. Goldman, PharmD, BCPS
Director, Pharmacotherapy Services, Department of Pharmacy, Cleveland Clinic, Cleveland, OH

Radhika Nair, PhD
Health Sciences Researcher, Abbott Laboratories, Austin, TX*

Correspondence: Morton P. Goldman, PharmD, BCPS, Department of Pharmacy, QQb5, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

*At the time this article was written, Dr. Nair was Outcomes Research Specialist, Department of Pharmacy, Cleveland Clinic, Cleveland, OH.

Dr. Goldman reported that he has received fees for serving on speakers’ bureaus for Enzon Pharmaceuticals, Wyeth Pharmaceuticals, Abbott Laboratories, Schering-Plough Corp., Forest Laboratories, and Pfizer Inc., and that he has received honoraria for writing from Wyeth.

Dr. Nair reported that she receives a salary from Abbott Laboratories (her current employer) and that she has received honoraria for writing from Wyeth.

The authors reported that they prepared this article without assistance from any medical education company.